ALNA
$1.12
Allena Pharmaceuticals
($.02)
(1.75%)
ALNA
Earnings Whisper ®
N/A
1st Quarter March 2021
Consensus:  ($0.20)
Revenue:  N/A
Tuesday
Jun 8
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ALNA reports earnings?
Beat
Meet
Miss

Where is ALNA's stock price going from here?
Up
Flat
Down
Stock chart of ALNA
Analysts
Summary of analysts' recommendations for ALNA
Score
Grade
Pivots
Resistance
$1.21
$1.17
$1.14

$1.10

Support
$1.07
$1.03
$1.00
Tweet
Growth
Description
Allena Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in developing and commercializing oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders primarily in the United States. The companys product candidate includes ALLN-177 and ALLN-346 which are in clinical stages. Allena Pharmaceuticals, Inc. is headquartered in Newton, Massachusetts.